XML 18 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details) (USD $)
3 Months Ended 9 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock in public offering (in shares)     3,336,800  
Purchase price of common stock issued (in dollars per share)     $ 2.00  
Warrants to purchase common stock (in shares) 1,668,400   1,668,400  
Exercise price of warrants (in dollars per share) $ 2.81   $ 2.81  
Net proceeds after expenses from offering     $ 5,944,000 $ 0
Stock Compensation Expense [Abstract]        
Stock based compensation expense 178,000 138,000 462,000 410,000
Aggregate Intrinsic Value [Abstract]        
Number of options for aggregate intrinsic value (in shares) 327,500   327,500  
Weighted-Average Grant Date Fair Value [Roll Forward]        
Number of shares withheld to pay income tax withholding (in shares)     57,680  
Stock Options [Member]
       
Number of Shares [Roll Forward]        
Outstanding at June 30, 2013 (in shares)     1,063,750  
Granted (in shares)     419,735  
Exercised (in shares)     (9,375) 0
Forfeited (in shares)     (23,625)  
Expired (in shares)     (191,250)  
Outstanding at March 31, 2014 (in shares) 1,259,235   1,259,235  
Vested and Expected to Vest at March 31, 2014 (in shares) 1,067,000   1,067,000  
Exercisable at March 31, 2014 (in shares) 587,007   587,007  
Weighted-Average Exercise Price Per Share [Roll Forward]        
Balance at June 30, 2013 (in dollars per share)     $ 2.36  
Granted (in dollars per share)     $ 2.08  
Exercised (in dollars per share)     $ 2.32  
Forfeited (in dollars per share)     $ 2.28  
Expired (in dollars per share)     $ 3.43  
Outstanding at March 31, 2014 (in dollars per share) $ 2.11   $ 2.11  
Vested and Expected to Vest at March 31, 2014 (in dollars per share) $ 2.05   $ 2.05  
Exercisable at March 31, 2014 (in dollars per share) $ 2.40   $ 2.40  
Weighted-Average Remaining Contractual Life [Abstract]        
Outstanding at March 31, 2014     2 years 8 months 12 days  
Vested and Expected to Vest at March 31, 2014     2 years 4 months 24 days  
Exercisable at March 31, 2014     1 year 6 months  
Aggregate Intrinsic Value [Abstract]        
Outstanding at March 31, 2014 231,000   231,000  
Vested and Expected to Vest at March 31, 2014 195,000   195,000  
Exercisable at March 31, 2014 85,000   85,000  
Aggregate intrinsic value of options exercised     $ 4,000  
Restricted Stock [Member]
       
Number of Shares [Roll Forward]        
Balance at June 30, 2013 (in shares)     390,003  
Granted (in shares)     452,500  
Vested (in shares)     (181,665)  
Forfeited (in shares)     (33,334)  
Outstanding at March 31, 2014 (in shares) 627,504   627,504  
Weighted-Average Grant Date Fair Value [Roll Forward]        
Balance at June 30, 2013 (in dollars per share)     $ 1.81  
Granted (in dollars per share)     $ 2.18  
Vested (in dollars per share)     $ 1.84  
Forfeited (in dollars per share)     $ 1.81  
Outstanding at March 31, 2014 (in dollars per share) $ 2.07   $ 2.07  
Warrants [Member]
       
Number of Shares [Roll Forward]        
Balance at June 30 (in shares)     1,125,000  
Warrants granted (in shares)     1,729,420  
Outstanding at March 31, 2014 (in shares) 2,854,420   2,854,420  
Exercisable at March 31, 2014 (in shares) 1,186,020   1,186,020  
Weighted-Average Exercise Price Per Share [Roll Forward]        
Balance at June 30 (in dollars per share)     $ 2.64  
Warrants granted (in dollars per share)     $ 2.79  
Outstanding at March 31, 2014 (in dollars per share) $ 2.73   $ 2.73  
Exercisable at March 31, 2014 (in dollars per share) $ 2.61   $ 2.61